文献速递腹部CT

多排CT特征对胰腺神经内分泌肿瘤患者总生存结局的预后价值

The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors.
PubMed 文献 · Eur J Radiol · 2020-01-23

回顾性纳入71例经病理确诊的胰腺神经内分泌肿瘤患者,由两名放射科医师评估临床与影像信息,比较分化良好与分化不良肿瘤的差异。多因素分析显示淋巴结转移(HR 21.52,P=0.009)和门静脉期强化比<1.02(HR 30.89,P=0.024)是总生存的独立预后因素。

要点

  • 门静脉期强化比<1.02是总生存的独立预后因素(HR 30.89,P=0.024)。
  • 淋巴结转移是总生存的独立预后因素(HR 21.52,P=0.009)。
  • 分化不良PNET更易出现体积大、形态不规则、边缘不清、侵犯邻近组织及肝和淋巴结转移。

核心结论

  • 分化不良的胰腺神经内分泌肿瘤比分化良好者更具侵袭性。
  • 淋巴结转移和门静脉期强化比<1.02是胰腺神经内分泌肿瘤患者总生存较差的独立预后因素。

研究设计与样本

  • 回顾性纳入71例经病理确诊的胰腺神经内分泌肿瘤患者。
  • 由两名放射科医师评估临床和影像信息,比较多排CT上分化良好与分化不良肿瘤的差异。
  • 采用Cox比例风险模型确定总生存的危险因素,并以Kaplan-Meier生存分析和log-rank检验比较不同亚组。

关键影像表现/征象

  • 分化不良PNET较分化良好者更常出现症状、肿瘤标志物异常、直径更大、形态不规则、边缘不清、侵犯邻近组织、肝和淋巴结转移以及强化比更低(P<0.05)。
  • 边缘不清、形态不规则、分化差、3级病变、无功能状态、肿瘤标志物水平异常、侵犯邻近组织、淋巴结和肝转移及强化比更低者总生存下降(log-rank P<0.05)。

诊断标准与关键数值

  • 全队列中位生存期为36个月,5年生存率为84.8%。
  • 多因素分析中淋巴结转移风险比21.52(P=0.009),门静脉期强化比<1.02风险比30.89(P=0.024)。

临床应用与阅片要点

  • 阅片时可关注门静脉期强化比是否<1.02,该阈值对应总生存较差的独立预后因素。
  • 报告中应描述淋巴结转移、边缘是否清晰、形态是否规则及有无邻近组织侵犯,这些征象与总生存下降相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the prognostic value of multidetector CT in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors (PNETs).

METHOD: Seventy-one patients pathologically diagnosed with PNETs were retrospectively included. The clinical and imaging information was evaluated by two radiologists. The difference between well-differentiated and poorly differentiated PNETs was analyzed. Cox proportional hazards models were created to determine the risk factors for overall survival. Kaplan-Meier survival analyses with log-rank tests were used among different subgroups of patients with PNETs.

RESULTS: In the whole cohort, the median survival was 36 months, and the 5-year survival rate was 84.8 %. Patients with poorly differentiated PNETs were more likely to present with symptoms, abnormal tumor markers, larger diameters, irregular shapes, ill-defined margins, invasion into nearby tissues, liver and lymph node metastases, and lower enhancement ratio than those with well-differentiated PNETs (P < 0.05). In the multivariate analysis, lymph node metastases (hazard ratio: 21.52, P = 0.009) and a portal enhancement ratio less than 1.02 (hazard ratio: 30.89, P = 0.024) were significant factors for overall survival. Overall survival decreased with an ill-defined margin, irregular shape, poor differentiation, grade 3 disease, nonfunctional status, abnormal tumor marker levels, invasion into nearby tissues, lymph node and liver metastases, and lower enhancement ratio (log-rank P < 0.05).

CONCLUSIONS: Poorly differentiated PNETs were more aggressiveness than well-differentiated PNETs. Lymph node metastases and a portal enhancement ratio < 1.02 were independent prognostic factors for worse overall survival outcomes in patients with PNETs.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Yang B, Chen HY, Zhang XY, et al. The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors. Eur J Radiol. 2020. PMID: 31991300. doi:10.1016/j.ejrad.2020.108847

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。